ENZY - Enzymotec Ltd. - Ordinary Share

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
11.85
0.00 (0.00%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close11.85
Open11.85
Bid0.00 x 0
Ask0.00 x 0
Day's Range11.85 - 11.90
52 Week Range11.85 - 11.90
Volume98,559
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Enzymotec Ltd. :ENZY-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018
    Capital Cube6 months ago

    Enzymotec Ltd. :ENZY-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018

    Categories: Yahoo FinanceGet free summary analysis Enzymotec Ltd. reports financial results for the quarter ended September 30, 2017. Highlights Summary numbers: Revenues of USD 13.67 million, Net Earnings of USD 0.42 million. Gross margins widened from 66.03% to 69.53% compared to the same period last year, operating (EBITDA) margins now 7.02% from 1.27%. Change in operating cash ... Read more (Read more...)

  • Associated Press7 months ago

    Enzymotec posts 3Q profit

    The Migdal Haemeq, Israel-based company said it had net income of 2 cents per share. Earnings, adjusted for stock option expense and costs related to mergers and acquisitions, came to 7 cents per share. ...

  • Reuters8 months ago

    Israeli flavour firm Frutarom to buy remaining 81 pct of Enzymotec

    Israeli flavour and fine ingredients company Frutarom Industries said on Sunday it agreed to acquire the 81 percent of special nutrition firm Enzymotec it doesn't already own for $11.9 a share, or about $168 million. Frutarom had acquired in prior transactions 19 percent of Enzymotec for $42 million, reflecting an average share price of $9.6 and announced its intention to make a tender offer for Enzymotec shares. Enzymotec will become a wholly owned subsidiary of Frutarom and be delisted from trading.

  • Enzymotec Ltd. :ENZY-US: Earnings Analysis: Q2, 2017 By the Numbers : October 5, 2017
    Capital Cube9 months ago

    Enzymotec Ltd. :ENZY-US: Earnings Analysis: Q2, 2017 By the Numbers : October 5, 2017

    Categories: Yahoo FinanceGet free summary analysis Enzymotec Ltd. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 13.02 million, Net Earnings of USD -2.31 million. Gross margins narrowed from 69.99% to 50.24% compared to the same period last year, operating (EBITDA) margins now -14.43% from 6.99%. Change in operating cash ... Read more (Read more...)

  • ACCESSWIRE10 months ago

    Corporate News Blog - Genetic Technologies Announces Comprehensive Review of Strategic Alternatives

    Research Desk Line-up: Enzymotec Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 28, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Genetic ...

  • Associated Press10 months ago

    Enzymotec reports 2Q loss

    On a per-share basis, the Migdal Haemeq, Israel-based company said it had a loss of 10 cents. Losses, adjusted for stock option expense, came to 6 cents per share. The maker of lipid-based nutritional ...

  • ACCESSWIRE10 months ago

    Investor Network: Enzymotec Ltd. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 16, 2017 / Enzymotec Ltd. (NASDAQ: ENZY ) will be discussing their earnings results in their Q2 Earnings Call to be held August 16, 2017 at 8:30 AM Eastern Time. To listen ...